Cargando…

Common Variants in PLXNA4 and Correlation to CSF-related Phenotypes in Alzheimer's Disease

The Plexin-A 4 (PLXNA4) gene, has recently been identified in genome wide association studies (GWAS), as a novel genetic player associated with Alzheimer's disease (AD). Additionally, PLXNA4 genetic variations were also found to increase AD risk by tau pathology in vitro. However, the potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Qiu, Sun, Yong-An, Zong, Yu, Chen, Chun, Wang, Hui-Fu, Tan, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305543/ https://www.ncbi.nlm.nih.gov/pubmed/30618575 http://dx.doi.org/10.3389/fnins.2018.00946

Ejemplares similares

Rare Variants in PLXNA4 and Parkinson’s Disease
por: Schulte, Eva C., et al.
Publicado: (2013)

Rare variant analysis of PLXNA1 in Parkinson's disease in the Chinese population
por: Li, Chunyu, et al.
Publicado: (2022)

CircPLXNA2 Affects the Proliferation and Apoptosis of Myoblast through circPLXNA2/gga-miR-12207-5P/MDM4 Axis
por: Dong, Xu, et al.
Publicado: (2023)

Biallelic and monoallelic variants in PLXNA1 are implicated in a novel neurodevelopmental disorder with variable cerebral and eye anomalies
por: Dworschak, Gabriel C., et al.
Publicado: (2021)

Analysis of PLXNA1, NRP1, and NRP2 variants in a cohort of patients with isolated hypogonadotropic hypogonadism
por: Men, Meichao, et al.
Publicado: (2021)

Circular RNA expression profiling reveals that circ-PLXNA1 functions in duck adipocyte differentiation
por: Wang, Laidi, et al.
Publicado: (2020)

FRI047 Clinical Characteristics Of Patients With Morbid Obesity With Semaphorines (SEMA3D,E,G) And PLXNA3&4 Gene Variants
por: Berra, Maddie, et al.
Publicado: (2023)

Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response?
por: Paszkowiak, Maria, et al.
Publicado: (2023)

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
por: Dong, Ruocheng, et al.
Publicado: (2023)

Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
por: Lopez-Font, Inmaculada, et al.
Publicado: (2015)

A Surgical Method to Improve the Homeostasis of CSF for the Treatment of Alzheimer’s Disease
por: Qin, Yang, et al.
Publicado: (2016)

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2018)

Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer’s Disease: The Paradigmatic Example of CSF
por: Canevelli, Marco, et al.
Publicado: (2019)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease
por: Huang, Ling-Chun, et al.
Publicado: (2022)

Automation vs. Experience: Measuring Alzheimer’s Beta-Amyloid 1–42 Peptide in the CSF
por: Kollhoff, Alexander L., et al.
Publicado: (2018)

CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer’s Disease
por: Karami, Azadeh, et al.
Publicado: (2019)

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD
por: Schindler, Suzanne Elizabeth, et al.
Publicado: (2015)

CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade
por: Yang, Xianfeng, et al.
Publicado: (2012)

An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism
por: Razzaq, Misbah, et al.
Publicado: (2021)

MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway
por: Wang, Wei-Wei, et al.
Publicado: (2019)

Amylin Receptor: A Common Pathophysiological Target in Alzheimer’s Disease and Diabetes Mellitus
por: Fu, Wen, et al.
Publicado: (2013)

Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria
por: Ferreira, Daniel, et al.
Publicado: (2014)

The Connected Steady State Model and the Interdependence of the CSF Proteome and CSF Flow Characteristics
por: Metzger, Fabian, et al.
Publicado: (2017)

Induction of PLXNA4 Gene during Neural Differentiation in Human Umbilical-Cord-Derived Mesenchymal Stem Cells by Low-Intensity Sub-Sonic Vibration
por: Cho, Hyunjin, et al.
Publicado: (2022)

Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer’s Disease Status and Risk Genotype
por: Lana, Erica, et al.
Publicado: (2019)

Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer’s disease risk
por: Ma, Jin, et al.
Publicado: (2022)

Alzheimer’s Disease: From Genetic Variants to the Distinct Pathological Mechanisms
por: Sun, Qiying, et al.
Publicado: (2017)

SZT2 variants associated with partial epilepsy or epileptic encephalopathy and the genotype-phenotype correlation
por: Luo, Sheng, et al.
Publicado: (2023)

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
por: Tang, Lian, et al.
Publicado: (2022)

TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
por: Song, Ya-Nan, et al.
Publicado: (2019)

Clinical characteristics and genotype-phenotype correlation analysis of familial Alzheimer’s disease patients with pathogenic/likely pathogenic amyloid protein precursor mutations
por: Liu, Yingzi, et al.
Publicado: (2022)

Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients
por: Berezhnoy, Georgy, et al.
Publicado: (2023)

A Candidate Regulatory Variant at the TREM Gene Cluster Confer Alzheimer’s Disease Risk by Modulating Both Amyloid-β Pathology and Neuronal Degeneration
por: Tian, Mei-Ling, et al.
Publicado: (2019)

Regulation of CSF and Brain Tissue Sodium Levels by the Blood-CSF and Blood-Brain Barriers During Migraine
por: Ghaffari, Hamed, et al.
Publicado: (2020)

Sleep Time Estimated by an Actigraphy Watch Correlates With CSF Tau in Cognitively Unimpaired Elders: The Modulatory Role of APOE
por: López-García, Sara, et al.
Publicado: (2021)

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
por: Liguori, Claudio, et al.
Publicado: (2018)

Common microRNA regulated pathways in Alzheimer’s and Parkinson’s disease
por: Awuson-David, Betina, et al.
Publicado: (2023)

Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience
por: Cotta Ramusino, Matteo, et al.
Publicado: (2021)

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
por: Guo, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kqo1ob0t9tjcnjjbngd7duppqa